Skip to content

Author

Yuko Ono

We have 2 of 11 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Association between empagliflozin exposure and skeletal muscle degeneration in patients with heart failure

Sodium–glucose co-transporter 2 inhibitors (SGLT2i) have become essential in the management of heart failure. Their prognostic benefits are consistent across older adults, frail, and underweight patients, but there may be potential adverse effects on the skeletal muscle. In this prospective single-centre observational...

Tatsuya Nishikawa, Nobuto Nakanishi, Kayo Osawa et al. · 0 citations
Open access Jul 2026

Adenosine 5'-monophosphate prevents sepsis-associated muscle wasting by activating AMPK and suppressing IL-1β inflammatory cytokines

It is demonstrated that AMP effectively mitigates SAMW by activating AMPK and suppressing IL-1β-mediated molecular pathways and highlighting the potential of AMP as a novel therapeutic agent for preserving skeletal muscle functionality and morphology in sepsis.

I. Yoshihara, Narumi Yoshihara, K. Hanafusa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.